Literature DB >> 33303682

Tumor Necrosis Factor α Receptor Type 1 Activation in the Hypothalamic Paraventricular Nucleus Contributes to Glutamate Signaling and Angiotensin II-Dependent Hypertension.

Clara Woods1, Jose Marques-Lopes1, Natalina H Contoreggi1, Teresa A Milner1,2, Virginia M Pickel1, Gang Wang1, Michael J Glass3.   

Abstract

There are significant neurogenic and inflammatory influences on blood pressure, yet the role played by each of these processes in the development of hypertension is unclear. Tumor necrosis factor α (TNFα) has emerged as a critical modulator of blood pressure and neural plasticity; however, the mechanism by which TNFα signaling contributes to the development of hypertension is uncertain. We present evidence that following angiotensin II (AngII) infusion the TNFα type 1 receptor (TNFR1) plays a key role in heightened glutamate signaling in the hypothalamic paraventricular nucleus (PVN), a key central coordinator of blood pressure control. Fourteen day administration of a slow-pressor dose of AngII in male mice was associated with transcriptional and post-transcriptional (increased plasma membrane affiliation) regulation of TNFR1 in the PVN. Further, TNFR1 was shown to be critical for elevated NMDA-mediated excitatory currents in sympathoexcitatory PVN neurons following AngII infusion. Finally, silencing PVN TNFR1 prevented the increase in systolic blood pressure induced by AngII. These findings indicate that TNFR1 modulates a cellular pathway involving an increase in NMDA-mediated currents in the PVN following AngII infusion, suggesting a mechanism whereby TNFR1 activation contributes to hypertension via heightened hypothalamic glutamate-dependent signaling.SIGNIFICANCE STATEMENT Inflammation is critical for the emergence of hypertension, yet the mechanisms by which inflammatory mediators contribute to this dysfunction are not clearly defined. We show that tumor necrosis factor α receptor 1 (TNFR1) in the paraventricular hypothalamic nucleus (PVN), a critical neuroregulator of cardiovascular function, plays an important role in the development of hypertension in mice. In the PVN, TNFR1 expression and plasma membrane localization are upregulated during hypertension induced by angiotensin II (AngII). Further, TNFR1 activation was essential for NMDA signaling and the heightening NMDA currents during hypertension. Finally, TNFR1 silencing in the PVN inhibits elevated blood pressure induced by AngII. These results point to a critical role for hypothalamic TNFR1 signaling in hypertension.
Copyright © 2021 the authors.

Entities:  

Keywords:  NMDA receptor; blood pressure; cytokine; excitatory neural transmission; inflammation; neural plasticity

Year:  2020        PMID: 33303682      PMCID: PMC7888211          DOI: 10.1523/JNEUROSCI.2360-19.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

1.  Methods of detection of the transcription factor NF-kappa B in rat hippocampal slices.

Authors:  Marion P Butler; Paul N Moynagh; John J O'Connor
Journal:  J Neurosci Methods       Date:  2002-09-30       Impact factor: 2.390

2.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Eric Lazartigues; Joseph Francis
Journal:  Cardiovasc Res       Date:  2011-09-27       Impact factor: 10.787

3.  Quantitative ultrasensitive bright-field RNA in situ hybridization with RNAscope.

Authors:  Hongwei Wang; Nan Su; Li-Chong Wang; Xingyong Wu; Son Bui; Allissa Nielsen; Hong-Thuy Vo; Yuling Luo; Xiao-Jun Ma
Journal:  Methods Mol Biol       Date:  2014

4.  Tumor necrosis factor receptor 1 inhibition is therapeutic for neuropathic pain in males but not in females.

Authors:  Tania Del Rivero; Roman Fischer; Fan Yang; Kathryn A Swanson; John R Bethea
Journal:  Pain       Date:  2019-04       Impact factor: 6.961

5.  Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension.

Authors:  Carmen Capone; Giuseppe Faraco; Jeffrey R Peterson; Christal Coleman; Josef Anrather; Teresa A Milner; Virginia M Pickel; Robin L Davisson; Costantino Iadecola
Journal:  J Neurosci       Date:  2012-04-04       Impact factor: 6.167

Review 6.  Tumor necrosis factor-α, kidney function, and hypertension.

Authors:  Eamonn Mehaffey; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

7.  Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Tracey A Van Kempen; Nicholas J Justice; Teresa A Milner; Michael J Glass
Journal:  Exp Neurol       Date:  2012-10-12       Impact factor: 5.330

8.  Redistribution of NMDA Receptors in Estrogen-Receptor-β-Containing Paraventricular Hypothalamic Neurons following Slow-Pressor Angiotensin II Hypertension in Female Mice with Accelerated Ovarian Failure.

Authors:  Jose Marques-Lopes; Ephrath Tesfaye; Sigal Israilov; Tracey A Van Kempen; Gang Wang; Michael J Glass; Virginia M Pickel; Costantino Iadecola; Elizabeth M Waters; Teresa A Milner
Journal:  Neuroendocrinology       Date:  2016-04-15       Impact factor: 4.914

9.  The concentration of tumor necrosis factor in the blood serum and in the urine and selected early organ damages in patients with primary systemic arterial hypertension.

Authors:  Anna Puszkarska; Arkadiusz Niklas; Jerzy Głuszek; Dawid Lipski; Karolina Niklas
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

10.  Regulation of arterial pressure by the paraventricular nucleus in conscious rats: interactions among glutamate, GABA, and nitric oxide.

Authors:  Marli C Martins-Pinge; Patrick J Mueller; C Michael Foley; Cheryl M Heesch; Eileen M Hasser
Journal:  Front Physiol       Date:  2013-01-09       Impact factor: 4.566

View more
  7 in total

Review 1.  Hypothalamic inflammation in metabolic disorders and aging.

Authors:  Anup Bhusal; Md Habibur Rahman; Kyoungho Suk
Journal:  Cell Mol Life Sci       Date:  2021-12-15       Impact factor: 9.261

2.  Cross-Talk between TNF-α and Angiotensin II in the Neural Control of Hypertension.

Authors:  Matheus Garcia Fragas; Gustavo Gastão Davanzo
Journal:  J Neurosci       Date:  2021-09-08       Impact factor: 6.167

3.  Angiotensin II Infusion Results in Both Hypertension and Increased AMPA GluA1 Signaling in Hypothalamic Paraventricular Nucleus of Male but not Female Mice.

Authors:  Gang Wang; Clara Woods; Megan A Johnson; Teresa A Milner; Michael J Glass
Journal:  Neuroscience       Date:  2022-01-07       Impact factor: 3.708

4.  Estrogen Receptor β Contributes to Both Hypertension and Hypothalamic Plasticity in a Mouse Model of Peri-Menopause.

Authors:  Teresa A Milner; Natalina H Contoreggi; Fangmin Yu; Megan A Johnson; Gang Wang; Clara Woods; Sanoara Mazid; Tracey A Van Kempen; Elizabeth M Waters; Bruce S McEwen; Kenneth S Korach; Michael J Glass
Journal:  J Neurosci       Date:  2021-05-03       Impact factor: 6.167

5.  Brain profiling in murine colitis and human epilepsy reveals neutrophils and TNFα as mediators of neuronal hyperexcitability.

Authors:  Sarah E Barnes; Kristy A Zera; Geoffrey T Ivison; Marion S Buckwalter; Edgar G Engleman
Journal:  J Neuroinflammation       Date:  2021-09-12       Impact factor: 8.322

6.  Angiotensin II differentially affects hippocampal glial inflammatory markers in young adult male and female mice.

Authors:  Teresa A Milner; Ryan X Chen; Diedreanna Welington; Batsheva R Rubin; Natalina H Contoreggi; Megan A Johnson; Sanoara Mazid; Jose Marques-Lopes; Roberta Marongiu; Michael J Glass
Journal:  Learn Mem       Date:  2022-09-06       Impact factor: 2.699

7.  Local ionotropic glutamate receptors are required to trigger and sustain ramping of sympathetic nerve activity by hypothalamic paraventricular nucleus TNFα.

Authors:  Aline A Mourão; Caroline G Shimoura; Mary Ann Andrade; Tamara T Truong; Gustavo R Pedrino; Glenn M Toney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-06       Impact factor: 5.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.